Table 3.
• Brain and kidneys |
|
– Increased levels of glial-programmed cell death. |
|
– Effects on cerebral blood flow |
|
– Modulation of the neurotransmitters γ-aminobutyric acid (GABA) and N-methyl-D-aspartate (NMDA) |
|
• Heart and kidneys |
|
– Hypotension |
|
– Decreased cardiac contractility |
|
– Cardiac arrhythmias |
|
• Immune system and kidneys |
|
– Refashioned immune reaction |
|
– Misdirected T-cells |
|
– Increased likelihood of infection |
|
• Hematological system and kidneys |
|
‘COAGULOPATHY’ with reduced platelet adhesion, compromised release of granule proteins, and β-thromboglobulin |
|
• Lungs and kidneys |
|
– Impaired gaseous exchange |
|
– Fluid overload |
|
– Increased inflammatory response |
|
Adopted from ref 70 |
|